LM
Luis Mas
Universidad Peruana Cayetano Heredia, Instituto Nacional de Enfermedades Neoplásicas, Oncosalud
Research areas: Medicine · Pulmonary and Respiratory Medicine · Lung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment · Lung Cancer Research Studies
0000-0002-2323-9271
Employment
-
Universidad Peruana Cayetano Heredia medical residency tutor2018 - Present
- 2003 - Present
-
Oncosalud1995 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (34)
- Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations Save
- A prognostic signature for lung adenocarcinoma in patients who have never smoked Save
- A prognostic signature for lung adenocarcinoma in people who have never smoked Save
- Comparison of Erlotinib vs. Osimertinib for Advanced or Metastatic EGFR Mutation-Positive Non-Small-Cell Lung Cancer Without Prior Treatment: A Network Meta-Analysis Save
- Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM) Save
- Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices Save
- Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP) Save
- Lung Cancer in Peru Save
- Lung Cancer in the Young Save
- ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer Save
- Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP) Save
- Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies Save
- Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America Save
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Save
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Save
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC Save
- Anemia as a prognostic factor in cancer patients,Anemia como factor pronóstico en pacientes con cáncer Save
- Gender and outcomes in non-small cell lung cancer: An old prognostic variable comes back for targeted therapy and immunotherapy? Save
- Implementation of computerized physician order entry for chemotherapy: A Latin American experience Save
- Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian national institute of neoplastic diseases,Citorreducción óptima en cáncer de ovario avanzado tratado con pacl… Save